Low Intensity Focused Ultrasound for Essential Tremor
This study is testing a new treatment called Low Intensity Focused Ultrasound (LIFUP) for people with Essential Tremor (ET). LIFUP uses sound waves to target a specific area of the brain (the ventral intermediate nucleus or Vim of the thalamus) that is involved in tremor. The study aims to see if LIFUP is safe, tolerable, and if it can help reduce tremor. You might be able to join if you are 18 to 90 years old, have a confirmed diagnosis of ET for at least 3 years, and are willing to follow the study plan. Researchers will measure how much your tremor improves using special sensors and doctor assessments over two weeks of treatment.
- Study design
- This is an open-label pilot study, meaning everyone knows what treatment is being given. It plans to enroll 20 participants.
- What's involved
- You would have six LIFUP treatment sessions over about two weeks. There will also be follow-up visits one and three months after treatment.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will have follow-up visits one and three months after your final treatment session.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- William Zeiger, MD, PhD · PRINCIPAL_INVESTIGATOR · University of California, Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Accelerometric Data of Tremor SeverityFrom enrollment until the end of treatment at 2 weeks
Accelerometric trackers will be used to quantify and track tremor severity at each study session.